Condorelli, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 15.402
AS - Asia 7.582
EU - Europa 2.437
SA - Sud America 1.457
AF - Africa 363
Continente sconosciuto - Info sul continente non disponibili 276
OC - Oceania 10
Totale 27.527
Nazione #
US - Stati Uniti d'America 15.071
SG - Singapore 4.693
CN - Cina 1.277
BR - Brasile 1.220
VN - Vietnam 708
IT - Italia 468
FI - Finlandia 429
IE - Irlanda 347
DE - Germania 250
NG - Nigeria 242
HK - Hong Kong 230
GB - Regno Unito 186
FR - Francia 182
CA - Canada 161
IN - India 149
NL - Olanda 113
SE - Svezia 112
AR - Argentina 93
BD - Bangladesh 83
RU - Federazione Russa 82
MX - Messico 71
IQ - Iraq 64
TR - Turchia 50
JP - Giappone 49
BE - Belgio 40
ID - Indonesia 36
EC - Ecuador 34
ES - Italia 30
PL - Polonia 30
ZA - Sudafrica 30
IL - Israele 29
CO - Colombia 28
UA - Ucraina 28
CZ - Repubblica Ceca 27
PK - Pakistan 25
VE - Venezuela 23
CL - Cile 22
CR - Costa Rica 22
MA - Marocco 22
SA - Arabia Saudita 21
JM - Giamaica 17
UZ - Uzbekistan 17
PH - Filippine 16
EG - Egitto 15
AE - Emirati Arabi Uniti 14
JO - Giordania 14
HN - Honduras 13
KE - Kenya 13
KR - Corea 13
MY - Malesia 13
PY - Paraguay 13
AZ - Azerbaigian 12
DZ - Algeria 12
RO - Romania 12
AT - Austria 10
GR - Grecia 10
UY - Uruguay 10
BB - Barbados 9
PT - Portogallo 9
ET - Etiopia 8
PE - Perù 8
AU - Australia 7
BG - Bulgaria 7
EE - Estonia 7
LT - Lituania 7
TH - Thailandia 7
GE - Georgia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BY - Bielorussia 5
CH - Svizzera 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
PR - Porto Rico 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
BS - Bahamas 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
IR - Iran 4
KG - Kirghizistan 4
RS - Serbia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CG - Congo 3
CU - Cuba 3
HU - Ungheria 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LY - Libia 3
MN - Mongolia 3
NI - Nicaragua 3
Totale 27.210
Città #
Singapore 2.074
Chandler 1.717
Wilmington 1.502
San Jose 910
Ashburn 868
The Dalles 763
Shanghai 570
San Mateo 553
Ann Arbor 473
Council Bluffs 470
New York 438
Dallas 433
Helsinki 427
Boardman 373
Dublin 344
Princeton 256
Leawood 248
Beijing 244
Lawrence 242
Benin City 241
Santa Clara 235
Ho Chi Minh City 228
Hong Kong 219
Los Angeles 189
Hanoi 180
Milan 174
Woodbridge 136
Fairfield 128
Paris 124
São Paulo 105
Phoenix 104
Columbus 91
Amsterdam 90
Buffalo 75
Seattle 75
London 66
Pune 62
Chicago 60
Toronto 59
San Diego 56
Rome 49
Rio de Janeiro 41
Brussels 39
Falkenstein 39
Tokyo 36
Atlanta 35
Brooklyn 35
Norwalk 35
Orem 32
Da Nang 31
Naples 31
Haiphong 30
Moscow 30
Baghdad 27
Brasília 27
Mexico City 27
Montreal 27
Munich 27
Warsaw 26
Falls Church 25
Houston 25
Boston 24
Chennai 24
San Francisco 24
Charlotte 23
Curitiba 22
Miami 22
Abbiategrasso 21
Belo Horizonte 21
Denver 21
Stockholm 19
Johannesburg 18
Philadelphia 18
Brno 17
Campinas 17
Tashkent 17
Dhaka 16
Queens 16
Figino 15
Frankfurt am Main 15
Guayaquil 15
Pittsburgh 15
San José 15
Kingston 14
Newark 14
North Bergen 14
Porto Alegre 14
Jakarta 13
Kocaeli 13
Las Vegas 13
Portland 13
Ribeirão Preto 13
Richmond 13
Baku 12
Bogotá 12
Changsha 12
Fortaleza 12
Hangzhou 12
Hải Dương 12
Nairobi 12
Totale 16.909
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 164
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 155
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 143
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 140
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 138
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 129
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 128
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 127
RNA (Epi)genetics in cardiovascular diseases 125
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 125
[Continuity of care in heart failure: pilot study of the Tuscany region]. 120
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 120
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 119
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 119
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 117
T cell costimulation blockade blunts pressure overload-induced heart failure 116
MicroRNAs and cardiac pathology 115
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 115
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 114
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 114
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 114
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 114
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 111
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 111
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 110
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 110
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 109
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 108
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 108
T Cell Costimulation Blockade Blunts Age-Related Heart Failure 107
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 107
Epigenetics : a new mechanism of regulation of heart failure? 106
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 106
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 106
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 106
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 106
Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction 104
Therapeutic use of microRNAs in myocardial diseases 104
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 104
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability 104
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair 104
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 103
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 103
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 103
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 102
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 102
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 101
Physiological myocardial hypertrophy: how and why? 101
Opposing roles of Akt and STAT3 in protection of the maternal heart from peripartum stress 101
Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation 101
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 99
Dr. John Ross Jr. 99
An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes 99
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 99
The possible role of chromosome X variability in hypertensive familiarity. 98
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 97
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 97
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 97
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 96
MicroRNAs in cardiovascular biology and heart disease 96
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part I: Synthesis, characterization,and myoblast proliferation and differentiation 96
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 95
Circulating microRNAs and aerobic fitness : the HUNT-study 95
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease 95
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 95
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 95
Reply to letter to the editor by Bonaventura et al 95
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 94
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 94
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 94
Uses and compositions comprising mirnas 94
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 94
The long noncoding RNA landscape in cardiovascular disease: a brief update. 93
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts 93
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 93
RBP and microRNA control of endothelial cell function 92
Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction 92
The emerging role of microRNAs in cardiovascular biology 91
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 91
p300/CBP modulates co-operation between MEF2A and TR/RxR 91
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 91
MicroRNAs in cardiovascular disease: an introduction for clinicians 91
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 91
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 90
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 90
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 90
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 89
Arterial remodeling and atherosclerosis: miRNAs involvement 89
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism 89
Epigenetics in heart failure 88
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 88
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 88
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease 87
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 87
Characterization of Myocardial Injury in Patients With COVID-19 87
Long non-coding RNA H19: a new avenue for RNA therapeutics in cardiac hypertrophy? 86
p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107 86
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation 86
Long noncoding RNAs and microRNAs in cardiovascular pathophysiology 86
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia 86
Totale 10.333
Categoria #
all - tutte 177.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.138 0 0 0 316 20 18 42 201 103 91 246 101
2022/20234.490 546 116 347 553 500 398 4 419 840 395 300 72
2023/20242.523 213 246 551 147 78 358 141 149 41 63 174 362
2024/20254.234 140 89 71 96 188 482 299 504 526 924 489 426
2025/20268.912 1.386 494 386 681 306 414 2.755 487 502 557 437 507
2026/20273.500 470 884 1.637 509 0 0 0 0 0 0 0 0
Totale 27.527